Investor Network Invites You to the GW Pharmaceuticals First …

LONDON, ENGLAND / ACCESSWIRE / February 6, 2017 / GW Pharmaceuticals plc (NASDAQ: GWPH) will host a conference call and live webcast to discuss the results of the first quarter 2017, to be held Tuesday, February 7, 2017 at 8:30 AM Eastern Time.

Live Event Information:

To participate, connect approximately 5 to 10 minutes before the beginning of the event.

If you are unable to participate during the live webcast, the event archive will be available at or

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex® (cannabidiol), which is in Phase 3 clinical development for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, Tuberous

... read more at: